Cellular and molecular mechanisms of tumor-induced T-cell tolerance

Pedro Horna, Eduardo M. Sotomayor

Research output: Contribution to journalReview article

25 Citations (Scopus)

Abstract

The spontaneous interaction between tumor cells and the immune system has been shown to result in reciprocal changes leading to a less immunogenic tumor and immune cells less capable or unable to mount an effective response against a growing malignancy. Although several mechanisms have been proposed to account for the ability of tumor cells to render immune cells less efficient, one that has gained particular attention relates to the recognition of tumor antigens by T-cells, a process that unfortunately leads to the induction and establishment of antigen-specific T-cell tolerance rather than T-cell priming. Here, we present the experimental and clinical evidence that help identify this remarkable barrier that the immune system itself and more specifically its mechanisms of tolerance induction has imposed to our efforts to effectively harness the immune system against tumors. In particular, we will discuss the central role of bone marrow-derived antigen-presenting cells (APCs) in the induction of this state of T-cell unresponsiveness and the potential role of the tumor microenvironment in determining the tolerogenic properties of these APCs. Finally, we provide information on receptor-ligands and intracellular signaling pathways that given their role in influencing the inflammatory properties of APCs are being exploited as targets to revert mechanisms of T-cell unresponsiveness in cancer.

Original languageEnglish (US)
Pages (from-to)41-53
Number of pages13
JournalCurrent Cancer Drug Targets
Volume7
Issue number1
DOIs
StatePublished - Feb 1 2007
Externally publishedYes

Fingerprint

T-Lymphocytes
Antigen-Presenting Cells
Immune System
Neoplasms
Tumor Microenvironment
Neoplasm Antigens
Bone Marrow
Ligands
Antigens

Keywords

  • Cancer vaccines
  • Immune tolerance
  • T-lymphocytes
  • Tumor antigens

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Cancer Research

Cite this

Cellular and molecular mechanisms of tumor-induced T-cell tolerance. / Horna, Pedro; Sotomayor, Eduardo M.

In: Current Cancer Drug Targets, Vol. 7, No. 1, 01.02.2007, p. 41-53.

Research output: Contribution to journalReview article

@article{e54c1f0f7b994c038baba24e2ef9219c,
title = "Cellular and molecular mechanisms of tumor-induced T-cell tolerance",
abstract = "The spontaneous interaction between tumor cells and the immune system has been shown to result in reciprocal changes leading to a less immunogenic tumor and immune cells less capable or unable to mount an effective response against a growing malignancy. Although several mechanisms have been proposed to account for the ability of tumor cells to render immune cells less efficient, one that has gained particular attention relates to the recognition of tumor antigens by T-cells, a process that unfortunately leads to the induction and establishment of antigen-specific T-cell tolerance rather than T-cell priming. Here, we present the experimental and clinical evidence that help identify this remarkable barrier that the immune system itself and more specifically its mechanisms of tolerance induction has imposed to our efforts to effectively harness the immune system against tumors. In particular, we will discuss the central role of bone marrow-derived antigen-presenting cells (APCs) in the induction of this state of T-cell unresponsiveness and the potential role of the tumor microenvironment in determining the tolerogenic properties of these APCs. Finally, we provide information on receptor-ligands and intracellular signaling pathways that given their role in influencing the inflammatory properties of APCs are being exploited as targets to revert mechanisms of T-cell unresponsiveness in cancer.",
keywords = "Cancer vaccines, Immune tolerance, T-lymphocytes, Tumor antigens",
author = "Pedro Horna and Sotomayor, {Eduardo M.}",
year = "2007",
month = "2",
day = "1",
doi = "10.2174/156800907780006940",
language = "English (US)",
volume = "7",
pages = "41--53",
journal = "Current Cancer Drug Targets",
issn = "1568-0096",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Cellular and molecular mechanisms of tumor-induced T-cell tolerance

AU - Horna, Pedro

AU - Sotomayor, Eduardo M.

PY - 2007/2/1

Y1 - 2007/2/1

N2 - The spontaneous interaction between tumor cells and the immune system has been shown to result in reciprocal changes leading to a less immunogenic tumor and immune cells less capable or unable to mount an effective response against a growing malignancy. Although several mechanisms have been proposed to account for the ability of tumor cells to render immune cells less efficient, one that has gained particular attention relates to the recognition of tumor antigens by T-cells, a process that unfortunately leads to the induction and establishment of antigen-specific T-cell tolerance rather than T-cell priming. Here, we present the experimental and clinical evidence that help identify this remarkable barrier that the immune system itself and more specifically its mechanisms of tolerance induction has imposed to our efforts to effectively harness the immune system against tumors. In particular, we will discuss the central role of bone marrow-derived antigen-presenting cells (APCs) in the induction of this state of T-cell unresponsiveness and the potential role of the tumor microenvironment in determining the tolerogenic properties of these APCs. Finally, we provide information on receptor-ligands and intracellular signaling pathways that given their role in influencing the inflammatory properties of APCs are being exploited as targets to revert mechanisms of T-cell unresponsiveness in cancer.

AB - The spontaneous interaction between tumor cells and the immune system has been shown to result in reciprocal changes leading to a less immunogenic tumor and immune cells less capable or unable to mount an effective response against a growing malignancy. Although several mechanisms have been proposed to account for the ability of tumor cells to render immune cells less efficient, one that has gained particular attention relates to the recognition of tumor antigens by T-cells, a process that unfortunately leads to the induction and establishment of antigen-specific T-cell tolerance rather than T-cell priming. Here, we present the experimental and clinical evidence that help identify this remarkable barrier that the immune system itself and more specifically its mechanisms of tolerance induction has imposed to our efforts to effectively harness the immune system against tumors. In particular, we will discuss the central role of bone marrow-derived antigen-presenting cells (APCs) in the induction of this state of T-cell unresponsiveness and the potential role of the tumor microenvironment in determining the tolerogenic properties of these APCs. Finally, we provide information on receptor-ligands and intracellular signaling pathways that given their role in influencing the inflammatory properties of APCs are being exploited as targets to revert mechanisms of T-cell unresponsiveness in cancer.

KW - Cancer vaccines

KW - Immune tolerance

KW - T-lymphocytes

KW - Tumor antigens

UR - http://www.scopus.com/inward/record.url?scp=33847387125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847387125&partnerID=8YFLogxK

U2 - 10.2174/156800907780006940

DO - 10.2174/156800907780006940

M3 - Review article

C2 - 17305477

AN - SCOPUS:33847387125

VL - 7

SP - 41

EP - 53

JO - Current Cancer Drug Targets

JF - Current Cancer Drug Targets

SN - 1568-0096

IS - 1

ER -